Literature DB >> 21357787

Novel approach to Gorlin syndrome: a patient treated with oral capecitabine.

Douglas F Beach1, Robert Somer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357787     DOI: 10.1200/JCO.2010.33.3393

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Amphiphilic Interpenetrating Networks for the Delivery of Hydrophobic, Low Molecular Weight Therapeutic Agents.

Authors:  Cody A Schoener; Heather N Hutson; Grace K Fletcher; Nicholas A Peppas
Journal:  Ind Eng Chem Res       Date:  2011-11-16       Impact factor: 3.720

2.  pH-responsive hydrogels with dispersed hydrophobic nanoparticles for the oral delivery of chemotherapeutics.

Authors:  Cody A Schoener; Heather N Hutson; Nicholas A Peppas
Journal:  J Biomed Mater Res A       Date:  2012-12-28       Impact factor: 4.396

3.  pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents.

Authors:  Cody A Schoener; Heather N Hutson; Nicholas A Peppas
Journal:  Polym Int       Date:  2012-04-11       Impact factor: 2.990

4.  Metastatic Basal cell carcinoma accompanying gorlin syndrome.

Authors:  Yeliz Bilir; Erkan Gokce; Banu Ozturk; Faik Alev Deresoy; Ruken Yuksekkaya; Emel Yaman
Journal:  Case Rep Oncol Med       Date:  2014-11-19

5.  Basal cell nevus syndrome (Gorlin-Goltz syndrome): genetic predisposition, clinical picture and treatment.

Authors:  Henryk Witmanowski; Paweł Szychta; Katarzyna Błochowiak; Arkadiusz Jundziłł; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2017-08-02       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.